Chambal Fertilisers and Chemicals Limited is a diversified agricultural inputs manufacturer and trader, operating primarily across urea, complex fertilizers, crop protection chemicals, biologicals, and seeds. The company is India's largest private sector urea producer, contributing close to 10% of domestic supply, while also holding roughly 5-6% market share in complex fertilizers like DAP and NPK. Historically, the business has operated on a cost-plus model for urea with steady EBIT margins of 14.6% in FY26, while its complex fertilizer trading business generated thinner 4% EBIT margins due to volatile global raw material costs. The higher-quality earnings reside in the crop protection, specialty nutrients, and biologicals segment, which delivered 30% revenue growth and 23.5% EBIT margins in FY26, reflecting a mix shift toward proprietary formulations rather than purely commoditized bulk nutrients.
The economics of this business persist through regulatory, structural, and integration barriers rather than pure pricing power. Urea manufacturing is heavily subsidized and governed by government policy, meaning margins are effectively guaranteed but capped; however, Chambal maintains a structural advantage by running its Gadepan plants beyond 100% capacity and securing energy consumption levels well below government norms, which yields direct energy gain accruals. For its newer ventures, the company benefits from high entry barriers, such as the INR 300-400 crore bank guarantee and strict 5-year execution timeline required under the upcoming NUP-2026 policy for new urea plants. Furthermore, its 240,000 MT technical ammonium nitrate (TAN) plant utilizes in-house captive ammonia feedstock with a 3-5% surplus, insulating margins from global LNG and ammonia price spikes, while the CFCL-TERI Centre of Excellence provides exclusive global commercial rights to jointly developed biological products, creating a proprietary pipeline that competitors cannot easily replicate.
The central inflection over the next 18-24 months is the transition from a pure fertilizer player to a diversified agri-inputs and industrial chemicals manufacturer, driven by the TAN plant commissioning and capacity expansions. By the end of 2026, the TAN project is expected to complete all marketing mix and product elements, targeting 75-80% capacity utilization in FY27 with an estimated production of 160,000 to 170,000 tons. Concurrently, the IMACID joint venture will expand phosphoric acid capacity from 500,000 to 700,000 MT by April-June 2027, and the crop protection segment will launch 14 new products in FY27. By late 2027 or early 2028, the business will feature a fully ramped TAN vertical generating high EBITDA per ton, a scaled biologicals franchise with products from the TERI collaboration, and a complex fertilizer business stabilized by 8.5 lakh tons of pre-tied NPK volumes, fundamentally altering the margin profile toward higher-value specialty outputs.
Management's execution trajectory shows a mixed but improving record on capital allocation and project delivery. They successfully delivered on the TAN plant capex timeline, with trial runs beginning in February 2026 and commercial production starting in April 2026, alongside delivering 30% YoY revenue growth in the crop protection segment against a guided 25% CAGR. However, they missed urea volume guidance due to repeated unplanned shutdowns, with FY26 sales at 34.06 lakh tons, and complex fertilizer EBIT margins slipped from 6.9% in FY25 to 4.4% in 9M-FY26 before recovering to 67% EBIT growth in Q1 FY27. The balance sheet remains conservatively managed with a net borrowing position of just INR 200 crores in Q1 FY27, and the company intends to maintain its dividend payout policy of approximately 25% of profits, though no major cash returns are planned for the next two years as capital is allocated toward the potential 1.3-million-ton fourth urea plant.
Earnings visibility hinges on the TAN plant ramping to 700 tons per day and the specialty nutrients business maintaining its 23.5% EBIT margins, which together are expected to drive standalone EBITDA margins above the 17% achieved in Q1 FY27. For this trajectory to hold, global raw material costs for ammonia and sulphur must stabilize, and the government must provide timely subsidy flows, given that subsidy receivables stood at INR 2,460 crores as of June 30, 2026. The single most important watchpoint is the potential entry of Reliance Industries into the TAN business, which could add large capacity and impact medium-term industry pricing and utilization; if this materializes alongside a delay in the NUP-2026 policy, the TAN margin uplift could be structurally capped, compressing the overall earnings delta.
companyname: Chambal Fertilisers and Chemicals Limited ticker: CHAMBLFERT sector: Fertilisers and Agri-inputs Chambal Fertilisers and Chemicals Limited (CFCL) is India's largest private sector urea manufacturer, with three plants at a single location in Gadepan, Rajasthan, producing about 3.37 million MT annually. The company was incorporated in 1985 and has evolved from a urea-centric business into a diversified agri-input platform. Urea still anchors the business - it contributed 60.4% of FY2...
Read the full report →capex, margin expansion
FY27 TAN capacity utilization guided at 75-80% driven by project commissioning
Guidance no_datamixed
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Chambal Fertilisers and Chemicals Limited and 4,900+ companies.
5-day free pass. No card required.